adesso expands its Life Science business area

With this move, adesso is consolidating more than one and a half decades of industry experience with healthcare companies and broad expert knowledge regarding technical processes, regulations, technologies and methods of software development and taking it to a new organisational level. In future, the Life Science business area will enable adesso to advise its customers on any and all questions concerning digitalisation in a separate, specially staffed unit with a professional team. The majority of these adesso industry experts are already certified according to the “Certified Professional for Medical Software” training standard.

These industry insiders are familiar with the different regulatory requirements in the life science and biotechnology industries, the strict quality requirements for the end product and correspondingly the production processes and application systems used.

The new European Medical Device Regulation (MDR) is affecting the entire healthcare sector. Requirements such as ISO13485, GxP, GAMP5 and CSV must also to be taken into consideration for digitalisation projects in the industry.

In the medical technology and pharmaceuticals field, adesso will combine its regulatory and industry-specific expertise with IT know-how to create efficient and agile solutions. In doing so, it draws on technologies from the fields of Artificial Intelligence (AI), Blockchain, Open Source Frameworks or Microsoft.

adesso advises on regulatory issues and designs and develops software for medical devices, including in the field of embedded systems, and validates these solutions according to MDR or CSV. Last year adesso also founded MediOne, an e-health start-up that implements communication solutions in the healthcare sector through a secure, mobile messenger.

Currently, laboratories and diagnostics are benefiting from knowledge surrounding the “digital laboratory” buzzword. This field is home to a wide range of elements, such as bioinformatics topics or AI concepts for genetic analyses as well as service portals and electronic patient files. adesso ensures that all requirements from the FDA and EMA are met when implementing digitalisation projects in laboratories – for example, the FDA Guidance for Data Integrity and Compliance with cGMP or the MHRA GxP Data Integrity Guidance.

In addition, adesso supports pharmaceutical trading companies in developing solutions for merchandise management systems or in the context of securPharm.

adesso will offer an insight into its Life Science expertise during an expert talk on 12 March 2019 at Soho House Berlin, where pharmaceutical industry leaders will discuss the topic of digitalisation in the healthcare sector. Topics will include “Leadership in the digital age”, “New technologies such as process optimisation, AI, robotics, big data and Blockchain” and “Competence profiles in the digital work environment”. The event will allow business leaders and managers to learn how digitalisation can be successfully realised in their companies, which core business processes will be subject to change, and which new business areas they should focus on. For enquiries and information visit: www.adesso.de/de/news/veranstaltungen/lifescience-executive-talk.jsp